Association between ceramides and coronary artery stenosis in patients with coronary artery disease

Chenchen Tu1, Lan Xie2, Zhenjie Wang3

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.

Insights

Plasma ceramide levels, particularly the ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), are linked to coronary artery stenosis severity. This finding aids in predicting acute coronary syndrome (ACS) risk.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Clinical Diagnostics

Background:

  • Coronary artery stenosis is a primary cause of heart disease, including acute coronary syndrome (ACS).
  • Ceramide species have been implicated in ACS and major adverse cardiovascular and cerebrovascular events (MACE).
  • Limited research exists on the correlation between plasma ceramide levels and coronary artery stenosis severity or disease onset.

Purpose of the Study:

  • To investigate the association between specific plasma ceramide species and the severity of coronary artery stenosis.
  • To explore the relationship between plasma ceramides, coronary artery stenosis, and the occurrence of acute coronary syndrome.

Main Methods:

  • Recruited 553 patients with suspected or confirmed coronary artery disease (CAD) undergoing angiography.
  • Measured four plasma ceramide species (Cer (d18:1/16:0), Cer (d18:1/18:0), Cer (d18:1/24:1), Cer (d18:1/24:0)) using LC-MS/MS.
  • Calculated ceramide ratios as indices and employed multiple logistic regression to develop a prognostic model for ACS risk.

Main Results:

  • A high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, elevated HbA1c%, and diagnoses of unstable angina (UAP) or acute myocardial infarction (AMI) were associated with more severe coronary artery stenosis.
  • A prognostic model was developed with an area under the curve (AUC) of 0.732 (95% CI: 0.642-0.822) for predicting ACS risk after adjusting for clinical factors.

Conclusions:

  • The severity of coronary artery stenosis correlates with a high Cer (d18:1/24:1) to Cer (d18:1/24:0) ratio, female gender, HbA1c%, and AMI.
  • The established prognostic model demonstrates good discrimination for ACS risk.
  • Further research is warranted to assess the long-term predictive value of ceramides for MACE.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
771
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
270
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
276
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
520
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
169
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
230